Recent Advances in Definitive Radiotherapy for Prostate Cancer

Recent Advances in Definitive Radiotherapy for Prostate Cancer

Definitive radiation therapy is a well-recognised curative treatment option for localised prostate cancer. A suitable technique, dose, target volume, and the option of a combination with androgen deprivation therapy needs to be considered. An optimal standard external beam radiotherapy includes curr...

Full description

Bibliographic Details
Main Author:	Michael Pinkawa
Format:	Article
Language:	English
Published:	European Medical Journal 2015-03-01
Series:	European Medical Journal Oncology
Subjects:	dose escalation external-beam radiotherapy Hypofractionation image-guided radiotherapy Intensity-Modulated Radiotherapy magnetic resonance imaging positron emission tomography Prostate Cancer simultaneous integrated boost
Online Access:	http://emjreviews.com/wp-content/uploads/Recent-Advances-in-Definitive-Radiotherapy-for-Prostate-Cancer.pdf

Similar Items

Recent Advances in Radiotherapy Modalities for Prostate Cancer
by: Jure Murgić, et al.
Published: (2022-01-01)

Optimizing External Beam Radiotherapy as per the Risk Group of Localized Prostate Cancer: A Nationwide Multi-Institutional Study (KROG 18-15)
by: Seo Hee Choi, et al.
Published: (2021-05-01)

The technical feasibility of an image-guided intensity-modulated radiotherapy (IG-IMRT) to perform a hypofractionated schedule in terms of toxicity and local control for patients with locally advanced or recurrent pancreatic cancer
by: Son Seok, et al.
Published: (2012-12-01)

Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: A systematic literature review
by: Martin Schmitt, et al.
Published: (2022-08-01)

Image Guided Radiotherapy by CBCT based Position Verification in High Risk Carcinoma Prostate - an Indian experience and review of literature
by: Rashi Agrawal
Published: (2013-12-01)

Preoperative Dose-Escalated Intensity-Modulated Radiotherapy (IMRT) and Intraoperative Radiation Therapy (IORT) in Patients with Retroperitoneal Soft-Tissue Sarcoma: Final Results of a Clinical Phase I/II Trial
by: Katharina Seidensaal, et al.
Published: (2023-05-01)

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
by: Sebastian Zschaeck, et al.
Published: (2018-12-01)

Hypofractionated Radiotherapy in Localized, Low–Intermediate-Risk Prostate Cancer: Current and Future Prospectives
by: Maria Chiara Lo Greco, et al.
Published: (2023-06-01)

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
by: Yeon Joo Kim, et al.
Published: (2018-04-01)

Long-term outcome of a moderately hypofractionated, intensity-modulated radiotherapy approach using an endorectal balloon for patients with localized prostate cancer
by: Bin S. Teh, et al.
Published: (2018-04-01)

Editorial: Online Adaptive MR-Guided Radiotherapy
by: Linda G. W. Kerkmeijer, et al.
Published: (2021-08-01)

Assessment of delivered dose in prostate cancer patients treated with ultra-hypofractionated radiotherapy on 1.5-Tesla MR-Linac
by: Lin-Rui Gao, et al.
Published: (2023-01-01)

Questionnaire-based Survey on Radiation Treatment Planning using Multimodality Facilities in Radiotherapy Centres across India: A Cross-sectional Study
by: NK Bhudevi Soubhagya, et al.
Published: (2023-02-01)

Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis
by: Chukwuka Eze, et al.
Published: (2019-09-01)

A Dosimetric Comparison between Conventional Fractionated and Hypofractionated Image-guided Radiation Therapies for Localized Prostate Cancer
by: Ming Li, et al.
Published: (2016-01-01)

Radiation treatment planning with embedded dose escalation
by: William T. Hrinivich, et al.
Published: (2019-08-01)

Ten Year Results of Extensive Nodal Radiotherapy and Moderately Hypofractionated Simultaneous Integrated Boost in Unfavorable Intermediate-, High-, and Very High-Risk Prostate Cancer
by: Nadia Gisella Di Muzio, et al.
Published: (2021-10-01)

Short course radiotherapy with simultaneous integrated boost for stage I-II breast cancer, early toxicities of a randomized clinical trial
by: Van Parijs Hilde, et al.
Published: (2012-06-01)

Feasibility of a simultaneously integrated boost concept for hypofractionated stereotactic radiotherapy of unresected brain metastases
by: Christine Kornhuber, et al.
Published: (2023-05-01)

Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer
by: Eckert Franziska, et al.
Published: (2013-01-01)

Long-Term Outcomes of Dose-Escalated Hypofractionated Radiotherapy in Localized Prostate Cancer
by: Antonio Lazo, et al.
Published: (2022-03-01)

PSMA-PET/MRI-Based Focal Dose Escalation in Patients with Primary Prostate Cancer Treated with Stereotactic Body Radiation Therapy (HypoFocal-SBRT): Study Protocol of a Randomized, Multicentric Phase III Trial
by: Constantinos Zamboglou, et al.
Published: (2021-11-01)

High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
by: Hideya Yamazaki, et al.
Published: (2018-09-01)

Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow
by: Lucia Clara Orlandini, et al.
Published: (2017-04-01)

Hypofractionated Postoperative Radiotherapy for Prostate Cancer: Is the Field Ready Yet?
by: Sean Mahase, et al.
Published: (2020-12-01)

Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients
by: Müller Arndt-Christian, et al.
Published: (2016-09-01)

Clinical outcomes of definitive whole pelvic radiotherapy for clinical lymph node metastatic prostate cancer
by: Keisuke Tsuchida, et al.
Published: (2020-09-01)

Moderately Escalated Hypofractionated (Chemo)Radiotherapy Delivered with Helical Intensity-Modulated Technique in Stage III Unresectable Non-Small Cell Lung Cancer
by: Vittorio eDonato, et al.
Published: (2013-11-01)

Value of Three-Dimensional Imaging Systems for Image-Guided Carbon Ion Radiotherapy
by: Yang Li, et al.
Published: (2019-03-01)

Dose-escalated radiotherapy with simultaneous integrated boost for bone metastases in selected patients with assumed favourable prognosis
by: Potkrajcic Vlatko, et al.
Published: (2022-12-01)

Ultra-Hypofractionated Stereotactic Body Radiotherapy for Localized Prostate Cancer: Clinical Outcomes, Patterns of Recurrence, Feasibility of Definitive Salvage Treatment, and Competing Oncological Risk
by: Marcin Miszczyk, et al.
Published: (2022-09-01)

MR-Guided Radiotherapy for Prostate Cancer
by: Boris R. Tocco, et al.
Published: (2020-12-01)

A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
by: Takuro Kainuma, et al.
Published: (2019-09-01)

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome
by: Una Ryg, et al.
Published: (2022-04-01)

A current review of dose-escalated radiotherapy in locally advanced non-small cell lung cancer
by: Ma Li, et al.
Published: (2019-03-01)

Current Approaches in Prostate Cancer Radiotherapy
by: Didem Karacetin
Published: (2021-01-01)

Leukotoxicity after moderately Hypofractionated radiotherapy versus conventionally fractionated dose escalated radiotherapy for localized prostate Cancer: a secondary analysis from a randomized study
by: Giuseppe Sanguineti, et al.
Published: (2019-01-01)

Salvage hypofractionated accelerated versus standard radiotherapy for the treatment of biochemical recurrence after radical prostatectomy (SHARE): the protocol of a prospective, randomized, open-label, superiority, multi-institutional trial
by: Geumju Park, et al.
Published: (2021-10-01)

Incorporating breath holding and image guidance in the adjuvant gastric cancer radiotherapy: a dosimetric study
by: Hu Weigang, et al.
Published: (2012-06-01)

Adaptive ultra‐hypofractionated whole‐pelvic radiotherapy in high‐risk and very high‐risk prostate cancer on 1.5‐Tesla MR‐Linac: Estimated delivered dose and early toxicity results
by: Linrui Gao, et al.
Published: (2024-03-01)